A four–amino acid peptide called CAQK has shown powerful brain-protective effects in animal models of traumatic brain injury. Delivered through a standard IV, it zeroes in on injured brain tissue, calming inflammation and reducing cell death while improving recovery. The peptide worked in both mice and pigs, whose brains are closer to humans in structure. Researchers are now preparing to move toward early human clinical trials.